Greenwich LifeSciences
GLSI
#8391
Rank
A$0.42 B
Marketcap
A$29.08
Share price
-2.73%
Change (1 day)
130.46%
Change (1 year)

Earnings for Greenwich LifeSciences (GLSI)

Earnings in 2026 (TTM): -A$32.27 Million

According to Greenwich LifeSciences's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$28.19 Million a decrease over its 2024 earnings that were of -A$24.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Greenwich LifeSciences from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$32.27 Million14.47%
2025 -A$28.19 Million16.52%
2024 -A$24.2 Million71.66%
2023 -A$14.1 Million16.01%
2022 -A$12.15 Million74.87%
2021 -A$6.95 Million146.7%
2020 -A$2.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-A$3.76 Million-88.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-A$0.12 Billion 234.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-A$0.34 Billion 921.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-A$0.14 Billion 311.39% Jersey